Td Asset Management Inc Acadia Pharmaceuticals Inc Transaction History

Td Asset Management Inc

  • $108 Billion
  • Q2 2025

A detailed history of Td Asset Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Td Asset Management Inc holds 45,000 shares of ACAD stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,000
Holding current value
$1.06 Million
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
BUY
$14.1 - $22.95 $634,500 - $1.03 Million
45,000 New
45,000 $970,000
Q2 2024

Aug 02, 2024
SELL
$14.62 - $18.42 $1.21 Million - $1.53 Million
-82,800 Reduced 78.04%
23,296 $378,000
Q1 2024

May 08, 2024
SELL
$17.79 - $30.86 $1.79 Million - $3.1 Million
-100,400 Reduced 48.62%
106,096 $1.96 Million
Q4 2023

Feb 12, 2024
SELL
$20.78 - $31.77 $398,976 - $609,984
-19,200 Reduced 8.51%
206,496 $6.47 Million
Q3 2023

Oct 27, 2023
BUY
$20.84 - $33.47 $1.07 Million - $1.72 Million
51,273 Added 29.4%
225,696 $4.7 Million
Q2 2023

Aug 09, 2023
BUY
$17.8 - $25.65 $1.02 Million - $1.47 Million
57,502 Added 49.18%
174,423 $4.18 Million
Q1 2023

May 10, 2023
BUY
$16.32 - $20.92 $221,952 - $284,512
13,600 Added 13.16%
116,921 $2.2 Million
Q4 2022

Feb 06, 2023
SELL
$14.2 - $18.63 $331,413 - $434,805
-23,339 Reduced 18.43%
103,321 $1.64 Million
Q3 2022

Nov 07, 2022
BUY
$14.11 - $18.27 $215,883 - $279,531
15,300 Added 13.74%
126,660 $2.04 Million
Q2 2022

Aug 04, 2022
BUY
$13.01 - $27.22 $200,354 - $419,188
15,400 Added 16.05%
111,360 $1.57 Million
Q1 2022

May 10, 2022
SELL
$20.94 - $27.5 $856,069 - $1.12 Million
-40,882 Reduced 29.88%
95,960 $2.32 Million
Q4 2021

Feb 10, 2022
BUY
$16.79 - $27.09 $197,970 - $319,418
11,791 Added 9.43%
136,842 $3.19 Million
Q3 2021

Nov 09, 2021
SELL
$15.78 - $24.77 $200,406 - $314,579
-12,700 Reduced 9.22%
125,051 $2.08 Million
Q2 2021

Aug 11, 2021
SELL
$19.4 - $27.42 $34,260 - $48,423
-1,766 Reduced 1.27%
137,751 $2.98 Million
Q1 2021

May 14, 2021
SELL
$25.02 - $54.99 $1.09 Million - $2.4 Million
-43,656 Reduced 23.83%
139,517 $3.6 Million
Q4 2020

Feb 16, 2021
SELL
$41.04 - $56.79 $2.43 Million - $3.36 Million
-59,200 Reduced 24.43%
183,173 $9.79 Million
Q3 2020

Nov 10, 2020
SELL
$36.42 - $57.0 $477,102 - $746,700
-13,100 Reduced 5.13%
242,373 $10 Million
Q2 2020

Aug 13, 2020
BUY
$39.26 - $52.73 $404,260 - $542,960
10,297 Added 4.2%
255,473 $12.4 Million
Q1 2020

May 15, 2020
SELL
$31.65 - $46.87 $1.2 Million - $1.78 Million
-37,943 Reduced 13.4%
245,176 $10.4 Million
Q4 2019

Feb 11, 2020
BUY
$36.21 - $51.4 $2.72 Million - $3.87 Million
75,214 Added 36.18%
283,119 $12.1 Million
Q3 2019

Nov 07, 2019
BUY
$22.22 - $44.01 $943,372 - $1.87 Million
42,456 Added 25.66%
207,905 $7.48 Million
Q2 2019

Aug 01, 2019
BUY
$23.32 - $28.12 $132,924 - $160,284
5,700 Added 3.57%
165,449 $4.42 Million
Q1 2019

May 08, 2019
BUY
$16.17 - $27.38 $202,125 - $342,250
12,500 Added 8.49%
159,749 $4.29 Million
Q4 2018

Feb 01, 2019
BUY
$14.32 - $22.92 $567,773 - $908,755
39,649 Added 36.85%
147,249 $2.38 Million
Q3 2018

Nov 01, 2018
BUY
$13.03 - $21.81 $1.4 Million - $2.35 Million
107,600 New
107,600 $2.23 Million
Q4 2017

Feb 02, 2018
SELL
$26.84 - $39.14 $879,305 - $1.28 Million
-32,761 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$29.49 - $38.37 $966,121 - $1.26 Million
32,761
32,761 $1.23 Million

Others Institutions Holding ACAD

# of Institutions
351
Shares Held
163M
Call Options Held
1.77M
Put Options Held
307K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.83B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email